Compound Detail
CHEMBL4297378
DURLOBACTAM SODIUM 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL4297378 |
| Name | DURLOBACTAM SODIUM |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | WHHNOICWPZIYKI-IBTYICNHSA-M |
| Parent Compound | CHEMBL4298137 |
| Active Moiety | CHEMBL4298137 |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
1
Publications
6
Known Names
2
Indications
4
Mechanisms
Molecular Properties
277.3
MW (Da)
-1.36
ALogP
5
HBA
2
HBD
130.2
PSA (Ų)
0.48
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2023 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Beta-lactamase inhibitor | INHIBITOR | Beta-lactamase | ✓ | ✓ |
| Beta-lactamase inhibitor | INHIBITOR | Beta-lactamase | ✓ | ✓ |
| Beta-lactamase inhibitor | INHIBITOR | Beta-lactamase | ✓ | ✓ |
| Beta-lactamase inhibitor | INHIBITOR | Beta-lactamase | ✓ | ✓ |
Indications
Bacterial Infections Infections
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 31663735 | 10.1021/acs.jmedchem.9b01279 | Unchecked | 5 |
Data from ChEMBL 36 via Core Engine